AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CAD 475.45 billion. The enterprise value is 561.50 billion.

Market Cap	475.45B
Enterprise Value	561.50B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Apr 15, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.33%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 82.84 and the forward PE ratio is 13.88.

PE Ratio	82.84
Forward PE	13.88
PS Ratio	5.67
PB Ratio	-107.42
P/TBV Ratio	n/a
P/FCF Ratio	19.46
P/OCF Ratio	18.22
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.91, with an EV/FCF ratio of 22.99.

EV / Earnings	97.83
EV / Sales	6.74
EV / EBITDA	13.91
EV / EBIT	19.53
EV / FCF	22.99

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.47M
Profits Per Employee	100,693
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 3.24 billion in taxes.

Income Tax	3.24B
Effective Tax Rate	35.83%

Stock Price Statistics

The stock price has increased by +4.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+4.79%
50-Day Moving Average	30.41
200-Day Moving Average	30.69
Relative Strength Index (RSI)	32.17
Average Volume (20 Days)	9,461

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, AbbVie had revenue of CAD 83.86 billion and earned 5.74 billion in profits. Earnings per share was 3.24.

Revenue	83.86B
Gross Profit	60.06B
Operating Income	28.95B
Pretax Income	9.05B
Net Income	5.74B
EBITDA	40.11B
EBIT	28.95B
Earnings Per Share (EPS)	3.24

Balance Sheet

The company has 7.21 billion in cash and 93.78 billion in debt, giving a net cash position of -86.58 billion.

Cash & Cash Equivalents	7.21B
Total Debt	93.78B
Net Cash	-86.58B
Net Cash Per Share	n/a
Equity (Book Value)	-4.43B
Book Value Per Share	-2.54
Working Capital	-19.51B

Cash Flow

In the last 12 months, operating cash flow was 26.09 billion and capital expenditures -1.66 billion, giving a free cash flow of 24.43 billion.

Operating Cash Flow	26.09B
Capital Expenditures	-1.66B
Depreciation & Amortization	11.14B
Net Borrowing	-416.18M
Free Cash Flow	24.43B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 1.19, which amounts to a dividend yield of 4.31%.

Dividend Per Share	1.19
Dividend Yield	4.31%
Dividend Growth (YoY)	28.68%
Years of Dividend Growth	2
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	4.31%
Earnings Yield	1.21%
FCF Yield	5.14%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8